BACKGROUND: Epithelioid glioblastoma (GBM) is characterized by its highly aggressive behavior and the presence of the BRAF V600E mutation. However, the impact and underlying mechanisms of the BRAF V600E mutation on GBM stemness and invasiveness are unknown. Dysregulation of N6-methyladenosine (m(6)A) modification is closely associated with the progression of various cancers. The role of m(6)A modification in BRAF V600E-mutant GBM has not been defined. METHODS: Functional assays were performed to evaluate the impact of BRAF V600E on stemness phenotypes of glioma stem-like cells (GSCs) and invasive phenotypes of GBM cells in vitro and in vivo. Mechanistic investigations involved m(6)A quantification, qPCR, western blotting, co-immunoprecipitation, MeRIP-seq, luciferase reporter assays, and transmission electron microscopy to elucidate the mechanism by which BRAF V600E regulates stemness and invasiveness. These findings were further supported by evidence from public GBM patient databases and tumor samples. RESULTS: We found that BRAF V600E significantly upregulated METTL3 expression via ERK signaling in GSCs and GBM cells, thereby promoting stemness and invasiveness. METTL3 established a positive feedback loop with BRAF V600E to facilitate m(6)A modification enrichment, thereby inducing autophagy. The BRAF V600E-driving stemness and invasiveness were autophagy-dependent. In vivo experiments showed that BRAF V600E-expressing GBM was responsive to both the METTL3 inhibitor STM2457 and the autophagy inhibitor HCQ. CONCLUSIONS: This study reveals that the BRAF V600E/MEK/ERK/METTL3 positive feedback loop promotes autophagy, driving the stemness of GSCs and the invasiveness of GBM cells via m(6)A modification in vitro and in vivo. Our results suggest that METTL3 and autophagy are promising therapeutic targets in BRAF V600E-mutant GBM. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13046-025-03623-0.
The BRAF V600E/MEK/ERK/METTL3 positive feedback loop regulates autophagy and promotes stemness and invasiveness in glioblastoma via m(6)A modification.
阅读:3
作者:Xie Yuan, Li Yan, Tang Meiqin, Li Zhi, Hu Wanming, Qiu Xiaoling, Wang Changyu, Zou Yunzhi, Lu Jie, Yuan Ze, Chen Furong, Yang Yuanzhong, Lu Chen, Sai Ke, Guo Ying, He Zhenqiang, Duan Hao, Mou Yonggao
| 期刊: | Journal of Experimental & Clinical Cancer Research | 影响因子: | 12.800 |
| 时间: | 2025 | 起止号: | 2025 Dec 30; 45(1):28 |
| doi: | 10.1186/s13046-025-03623-0 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
